Home/Filings/4/0001127602-22-022030
4//SEC Filing

Mandadi Tilak 4

Accession 0001127602-22-022030

CIK 0000064803other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 4:48 PM ET

Size

4.6 KB

Accession

0001127602-22-022030

Insider Transaction Report

Form 4
Period: 2022-08-31
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
  • Award

    Common Stock (RSU)

    2022-08-31+99,84799,847 total
Footnotes (1)
  • [F1]Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001872827

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:48 PM ET
Size
4.6 KB